ƽ

HypoThermosol® FRS

Animal component-free, defined hypothermic (2 - 8°C) preservation medium for a range of cell and tissue types

HypoThermosol® FRS

Animal component-free, defined hypothermic (2 - 8°C) preservation medium for a range of cell and tissue types

Catalog #
(Select a product)
Animal component-free, defined hypothermic (2 - 8°C) preservation medium for a range of cell and tissue types
Request Pricing Request Pricing

Product Advantages


  • Ready-to-use

  • Serum-free, protein-free

  • Animal component-free

  • cGMP manufactured with USP grade / highest-quality components

  • FDA master file

  • Sterility, endotoxin, and cell-based release testing

Overview

Improve and extend the preservation of cells, tissues, and organs with HypoThermosol® FRS. This ready-to-use, serum-free, protein-free, and animal component-free preservation medium is formulated to address the molecular-biological response of cells during the hypothermic (2 - 8°C) preservation process. HypoThermosol® FRS includes key ions at concentrations that balance the intracellular state at hypothermic temperatures. This medium has been subjected to sterility, endotoxin, and cell-based release testing and is manufactured under cGMPs with USP-grade components. Additional components include pH buffers, energy substrates, free radical scavengers, and osmotic/oncotic stabilizers.
Cell Type
Hematopoietic Stem and Progenitor Cells, Mesenchymal Stem and Progenitor Cells, Other, Pluripotent Stem Cells
Species
Human, Mouse, Non-Human Primate, Other, Rat
Application
Cryopreservation
Brand
Hypothermosol
Area of Interest
Stem Cell Biology
Formulation Category
Animal Component-Free, Serum-Free

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
07935, 07934, 07936, 07945
Lot #
All
Language
English
Document Type
Product Name
Catalog #
07935, 07934, 07936, 07945
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Educational Materials (6)

Publications (1)

PRDM3/16 regulate chromatin accessibility required for NKX2-1 mediated alveolar epithelial differentiation and function H. He et al. Nature Communications 2024 Sep

Abstract

While the critical role of NKX2-1 and its transcriptional targets in lung morphogenesis and pulmonary epithelial cell differentiation is increasingly known, mechanisms by which chromatin accessibility alters the epigenetic landscape and how NKX2-1 interacts with other co-activators required for alveolar epithelial cell differentiation and function are not well understood. Combined deletion of the histone methyl transferases Prdm3 and Prdm16 in early lung endoderm causes perinatal lethality due to respiratory failure from loss of AT2 cells and the accumulation of partially differentiated AT1 cells. Combination of single-cell RNA-seq, bulk ATAC-seq, and CUT&RUN data demonstrate that PRDM3 and PRDM16 regulate chromatin accessibility at NKX2-1 transcriptional targets critical for perinatal AT2 cell differentiation and surfactant homeostasis. Lineage specific deletion of PRDM3/16 in AT2 cells leads to lineage infidelity, with PRDM3/16 null cells acquiring partial AT1 fate. Together, these data demonstrate that NKX2-1-dependent regulation of alveolar epithelial cell differentiation is mediated by epigenomic modulation via PRDM3/16. Growth and differentiation of pulmonary epithelial cells is precisely controlled to form the alveoli that create the gas exchange region of the lung. Here, the authors demonstrate that epigenetic modulation of the genome by PRDM3/16 mediates NKX2-1 activity to control alveolar cell fate and differentiation during embryonic and perinatal lung development.